The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

Share Price Information for Marlowe (MRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 508.00
Bid: 506.00
Ask: 510.00
Change: 8.00 (1.60%)
Spread: 4.00 (0.791%)
Open: 505.00
High: 520.00
Low: 507.00
Prev. Close: 500.00
MRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - [Marlowe plc - 06 08 2021] - (CGWL)

9 Aug 2021 11:58

Form 8.3 - [Marlowe plc - 06 08 2021] - (CGWL)

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary Clients)
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeMARLOWE PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:RESTORE PLC AS AN ASSOCIATE OF THE CANACCORD GENUITY GROUP
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure06 AUGUST 2021
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”YESRESTORE PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:ORDINARY 50p
 InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:1,316,4721.7070  
(2) Cash-settled derivatives:    
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:1,316,4721.7070  

NOTE: 1,200 shares were transferred in by a discretionary client on 06/08/2021

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
ORDINARY 50pPurchase3,200749.9p
ORDINARY 50pPurchase1,000752p

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
NONE    

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
NONE       

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
NONE   

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:09 AUGUST 2021
Contact name:MARK ELLIOTT
Telephone number:01253 376539

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
22nd Feb 20215:20 pmRNSDirector/PDMR Shareholding
17th Feb 20213:30 pmRNSCapital Markets Day Replay
17th Feb 20217:00 amRNSCapital Markets Day and Trading Update
10th Feb 20217:00 amRNSNotice of Capital Markets Day
5th Feb 20217:00 amRNSIssue of Equity and Director/PDMR Shareholding
4th Feb 20217:00 amRNSAcquisition Hadrian Technology Limited
28th Jan 20212:45 pmRNSHolding(s) in Company
7th Jan 20217:00 amRNSAcquisition of WPL Limited
29th Dec 20204:40 pmRNSSecond Price Monitoring Extn
29th Dec 20204:36 pmRNSPrice Monitoring Extension
21st Dec 20207:00 amRNSAcquisition of DeltaNet International Limited
11th Dec 20206:07 pmRNSHolding(s) in Company
11th Dec 202011:25 amRNSResult of General Meeting
7th Dec 20207:00 amRNSAcquisition of Network of Staff Supporters Limited
3rd Dec 20207:00 amRNSHalf Year Results
1st Dec 20204:10 pmRNSCompletion of Acquisition
30th Nov 20207:00 amRNSAcquisition of Wrightway Health Limited
26th Nov 20203:30 pmRNSNotice of General Meeting
20th Nov 20207:00 amRNSCompletion of Refinancing
17th Nov 202011:59 amRNSHolding(s) in Company
3rd Nov 202010:58 amRNSHolding(s) in Company
2nd Nov 20207:00 amRNSAcquisition of Black & Banton
30th Oct 202011:55 amRNSHolding(s) in Company
29th Oct 20206:08 pmRNSHolding(s) in Company
29th Oct 20207:00 amRNSResults of the Placing
28th Oct 20205:08 pmRNSAcquisition of Ellis Whittam and Proposed Placing
30th Sep 202012:06 pmRNSResult of AGM
25th Sep 20207:00 amRNSAcquisition of Morgan Fire Protection Limited
9th Sep 20207:00 amRNSFurther re Acquisition of William Martin
2nd Sep 20207:00 amRNS2020 SAYE Scheme & Director/PDMR Shareholdings
31st Jul 20202:46 pmRNSIssue of Equity and Director/PDMR Shareholding
31st Jul 20207:00 amRNSAcquisitions
17th Jul 202012:20 pmRNSHolding(s) in Company
15th Jul 202011:20 amRNSResult of General Meeting
8th Jul 20204:03 pmRNSGrant of Share Options
8th Jul 20207:00 amRNSFinal Results
30th Jun 202011:57 amRNSHolding(s) in Company
26th Jun 20202:39 pmRNSResults of the Placing
26th Jun 20207:00 amRNSAcquisition of Elogbooks and Proposed Placing
29th May 20207:00 amRNSAcquisition of Deminos Consulting Limited
12th May 20207:00 amRNSYear End Trading Statement and COVID-19 Update
7th Apr 202012:40 pmRNSIssue of Equity
7th Apr 20207:00 amRNSDirector/PDMR Shareholding
31st Mar 20207:00 amRNSDisposal of non-core activities
31st Mar 20207:00 amRNSUpdate on COVID-19
24th Mar 202011:31 amRNSIssue of Equity
11th Mar 202011:24 amRNSDirector/PDMR Shareholding
10th Mar 20207:00 amRNSAcquisition of Solve HR Limited
9th Mar 20207:00 amRNSAcquisition of Managed Occupational Health Limited
3rd Feb 20207:00 amRNSAcquisition of Eurosafe UK Group Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.